OUD Pharmacogenomics FDA-approved AvertD pharmacogenomic test for opioid use disorder enables SOLVD Health to commercially offer pharmacogenomic testing as a service. This creates opportunities to engage addiction treatment centers, hospitals, clinics, and payer networks seeking personalized treatment approaches and improved patient outcomes.

Strategic Partnerships The addition of new board members and strategic advisor signals a growth trajectory; leverage this leadership to form partnerships with healthcare systems, diagnostics labs, and pharma companies to scale testing, co development, and distribution channels.

Preventive Health Positioned around Patient Intelligence, SOLVD Health can market predictive risk assessment and contextual health insights to care coordinators and primary care networks, enabling earlier interventions and reducing long term costs.

Data Analytics The company's emphasis on turning biological signals into predictive insights suggests opportunities to sell analytics platforms, dashboards, and EHR integrations to health systems and research partners.

Regional Growth Headquartered on the West Coast with a mid sized team, SOLVD Health can prioritize local and regional growth, targeting California based health systems, academic medical centers, and biotechnology partners, leveraging familiarity with the regulatory environment.